Literature DB >> 9825762

Northern analysis of type II iodothyronine deiodinase mRNA in rat Harderian gland.

O Araki1, M Murakami, Y Kamiya, Y Hosoi, T Ogiwara, H Mizuma, T Iriuchijima, M Mori.   

Abstract

It has been known that type II iodothyronine deiodinase activity is present in rat Harderian gland and the activity is significantly increased by isoproterenol administration. We have performed Northern analyses to study whether the transcript for type II iodothyronine deiodinase is expressed in rat Harderian gland and whether the isoproterenol stimulation of type II iodothyronine deiodinase activity in rat Harderian gland is due to the change in its mRNA level. Northern analyses have demonstrated that type II iodothyronine deiodinase mRNA, approximately 7.5 kb in size, is expressed in rat Harderian gland, and the mRNA levels as well as the deiodinase activities are greater in hypothyroid rats than those in euthyroid rats. Type II iodothyronine deiodinase mRNA levels and the deiodinase activities in Harderian gland were increased by isoproterenol administration, and the increase in the mRNA levels preceded that in the deiodinase activities. These results indicate that 7.5 kb transcript for type II iodothyronine deiodinase is expressed in rat Harderian gland and beta-adrenergic stimulation of type II iodothyronine deiodinase activity is due at least in part to the increase in its mRNA level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9825762     DOI: 10.1016/s0024-3205(98)00471-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Thyroid hormone activation in vascular smooth muscle cells is negatively regulated by glucocorticoid.

Authors:  Nagaoki Toyoda; Saori Yasuzawa-Amano; Emiko Nomura; Azusa Yamauchi; Kumiko Nishimura; Chizuko Ukita; Satoshi Morimoto; Atsushi Kosaki; Toshiji Iwasaka; John W Harney; P Reed Larsen; Mitsushige Nishikawa
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.